Peter Kolchinsky, PhD: Ideas That Refuse to Die

In the latest episode of Precision Signals, Sean Khozin speaks with Peter Kolchinsky, founder and managing partner of RA Capital Management.Peter’s perspective is shaped in part by his experience as the child of Soviet Jewish immigrants. His parents brought him a deep appreciation for education, hard work, entrepreneurship, and the opportunity to improve the systems around us.That mindset has guided his journey from scientist and virologist to biotech investor and institution builder.In this wide-ranging conversation, Sean and Peter discuss:• How Peter moved from studying biology to helping scientists translate discoveries into medicines• Why the biotech industry needs stronger institutional memory, including a willingness to learn from failed experiments• The limitations of AI in drug development, where generating a promising molecule is only the beginning of a years-long clinical learning process• Why China’s expanding clinical trial infrastructure may have a greater near-term impact on the pace of R&D than AI• How the FDA can be understood as a community of people working within a complex institution, rather than as an opaque gatekeeper• Why CEOs must define their role by what it takes to advance the mission, including advocacy for patients, innovation, and better policyA substantive discussion about immigration, science, entrepreneurship, AI, clinical trials, regulation, and what it means to build organizations that keep learning.